The Prostate

Cover image for Vol. 72 Issue 10

1 July 2012

Volume 72, Issue 10

Pages 1045–1157

  1. Rapid Communications

    1. Top of page
    2. Rapid Communications
    3. Original Articles
    4. Retraction
    1. A Hoxb13-driven reverse tetracycline transactivator system for conditional gene expression in the prostate (pages 1045–1051)

      Varsha Rao, Jamie C. Heard, Helya Ghaffari, Aminah Wali, Laura N. Mutton and Charles J. Bieberich

      Version of Record online: 1 FEB 2012 | DOI: 10.1002/pros.22490

  2. Original Articles

    1. Top of page
    2. Rapid Communications
    3. Original Articles
    4. Retraction
    1. Contrasting DNA damage checkpoint responses in epithelium of the human seminal vesicle and prostate (pages 1060–1070)

      Sari Jäämaa, Anna Sankila, Ville Rantanen, Karita Peltonen, Päivi M. Järvinen, Taija M. af Hällström, Mirja Ruutu, Kimmo Taari, Leif C. Andersson and Marikki Laiho

      Version of Record online: 9 NOV 2011 | DOI: 10.1002/pros.21509

    2. RhoC and guanine nucleotide exchange factor Net1 in androgen-unresponsive mouse mammary carcinoma SC-4 cells and human prostate cancer after short-term endocrine therapy (pages 1071–1079)

      Hirotoshi Kawata, Naoki Shimada, Tomoko Kamiakito, Kenji Komatsu, Tatsuo Morita, Toshio Ota, Masaya Obayashi, Kenya Shitara and Akira Tanaka

      Version of Record online: 14 NOV 2011 | DOI: 10.1002/pros.21511

    3. Overexpression of the VSSC-associated CAM, beta-2, enhances LNCaP cell metastasis associated behavior (pages 1080–1092)

      Keith H. Jansson, Jill E. Lynch, Nadia Lepori-Bui, Kirk J. Czymmek, Randall L. Duncan and Prof. Robert A. Sikes

      Version of Record online: 29 NOV 2011 | DOI: 10.1002/pros.21512

    4. The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer (pages 1093–1103)

      Tong Sun, Ming Yang, Shaoyong Chen, Steven Balk, Mark Pomerantz, Chen-Lin Hsieh, Myles Brown, Gwo-Shu Mary Lee and Philip W. Kantoff

      Version of Record online: 29 NOV 2011 | DOI: 10.1002/pros.22456

    5. Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance (pages 1117–1123)

      Katherine J. O'Malley, Gabrielle Langmann, Junkui Ai, Raquel Ramos-Garcia, Robert L. Vessella and Zhou Wang

      Version of Record online: 7 DEC 2011 | DOI: 10.1002/pros.22458

    6. High mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells (pages 1124–1132)

      Ichiro Takeuchi, Natsuki Takaha, Terukazu Nakamura, Fumiya Hongo, Kazuya Mikami, Kazumi Kamoi, Koji Okihara, Akihiro Kawauchi and Tsuneharu Miki

      Version of Record online: 27 DEC 2011 | DOI: 10.1002/pros.22460

    7. AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy (pages 1133–1139)

      Eli Rosenbaum, Shahnaz Begum, Mariana Brait, Marianna Zahurak, Leonel Maldonado, Leslie A. Mangold, Mario A. Eisenberger, Jonathan I. Epstein, Alan W. Partin, David Sidransky and Mohammad O. Hoque

      Version of Record online: 29 NOV 2011 | DOI: 10.1002/pros.22461

    8. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer (pages 1140–1149)

      Leslie Oleksowicz, Yin Liu, R. Bruce Bracken, Krishnanath Gaitonde, Barbara Burke, Paul Succop, Linda Levin, Zhongyun Dong and Dr. Shan Lu

      Version of Record online: 29 NOV 2011 | DOI: 10.1002/pros.22463

  3. Retraction

    1. Top of page
    2. Rapid Communications
    3. Original Articles
    4. Retraction
    1. You have free access to this content